Q2 & H1 FY20 financial Results

Dr. Reddy’s Laboratories announces the launch of FXR™ (obeticholic acid) in India
Business

Dr. Reddy’s Q2 & H1 FY20 Financial Results

November 5, 2019 Praveen Comments Off on Dr. Reddy’s Q2 & H1 FY20 Financial Results

. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the quarter and the half year ended September 30, 2019 under International Financial Reporting Standards (IFRS). […]